Coronavirus Vaccin
-
{
- All
- News
- Web Stories
-
Breakthrough: Universal Coronavirus Vaccine Designed By AI Passes Human Trial
Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans. Here is how this needle-free super-antigen aims to future-proof humanity against all future mutations.
-
Artificial Intelligence Creates Vaccine Aimed At Preventing Future Pandemics
Researchers say the technology has already been used to create and test a vaccine designed to protect against multiple coronaviruses.
-
Universal Coronavirus Vaccine? New Jab Targets Even Unknown Threats
Researchers have made a new coronavirus vaccine that could also protect against viruses we haven't found yet, to stop future pandemics.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
Catch Up Vaccination For Children; It Is Never Too Late
Vaccination For Children: Talk to your doctor if your child has missed any vaccinations.
-
'Bivalent' Booster For Omicron, Original Covid Strain Approved By UK
The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.
-
India's Covid Vaccination Coverage Exceeds 196.94 Crore: Health Ministry
India's cumulative COVID-19 vaccination coverage exceeded the 196.94 crores (1,96,94,40,932) mark today, informed the Ministry of Health and Family Welfare.
-
US Approves Covid Vaccine For Children 6 Months And Above
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.
-
"Covaxin Safe For Kids Aged 2-18": Here's What Bharat Biotech Says On Side-Effects
Data on Covaxin for children has been published online in The Lancet Infectious Diseases journal on June 16
-
EU Watchdog Reviews Adapted Pfizer Jab. Target: Omicron
Europe's medicines watchdog said Wednesday it has started to review an adapted version of Pfizer/BioNTech's anti-Covid jab in order to better protect against specific variants of the virus, including Omicron.
-
Over 3 Crore Covid Vaccine Doses Administered To 12-14 Age Group: Centre
Over three crore children in the age group of 12-14 years have been administered the first dose of the COVID-19 vaccine, said Union Health Minister Mansukh Mandaviya said on Tuesday.
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
Moderna Seeks US Approval For Covid Vaccine For Children Under 6
US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years.
-
Over 18.03 Crore Covid Vaccine Doses Available With States, UTs: Centre
More than 18.03 crore balanced and unutilized COVID vaccine doses are still available with states and Union Territories (UTs), informed the Ministry of Health and Family Welfare in its official statement on Monday.
-
Breakthrough: Universal Coronavirus Vaccine Designed By AI Passes Human Trial
Scientists have successfully tested an AI-designed universal coronavirus vaccine in humans. Here is how this needle-free super-antigen aims to future-proof humanity against all future mutations.
-
Artificial Intelligence Creates Vaccine Aimed At Preventing Future Pandemics
Researchers say the technology has already been used to create and test a vaccine designed to protect against multiple coronaviruses.
-
Universal Coronavirus Vaccine? New Jab Targets Even Unknown Threats
Researchers have made a new coronavirus vaccine that could also protect against viruses we haven't found yet, to stop future pandemics.
-
Serum Institute Seeks Inclusion Of Covid Jab 'Covovax' In CoWIN Portal
Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.
-
Centre's Panel Recommends Market Clearance To Covovax As Covid Booster: Report
An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India's Covid vaccine Covovax as a heterologous booster dose for adults, Press Trust of India reported.
-
Catch Up Vaccination For Children; It Is Never Too Late
Vaccination For Children: Talk to your doctor if your child has missed any vaccinations.
-
'Bivalent' Booster For Omicron, Original Covid Strain Approved By UK
The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.
-
India's Covid Vaccination Coverage Exceeds 196.94 Crore: Health Ministry
India's cumulative COVID-19 vaccination coverage exceeded the 196.94 crores (1,96,94,40,932) mark today, informed the Ministry of Health and Family Welfare.
-
US Approves Covid Vaccine For Children 6 Months And Above
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.
-
"Covaxin Safe For Kids Aged 2-18": Here's What Bharat Biotech Says On Side-Effects
Data on Covaxin for children has been published online in The Lancet Infectious Diseases journal on June 16
-
EU Watchdog Reviews Adapted Pfizer Jab. Target: Omicron
Europe's medicines watchdog said Wednesday it has started to review an adapted version of Pfizer/BioNTech's anti-Covid jab in order to better protect against specific variants of the virus, including Omicron.
-
Over 3 Crore Covid Vaccine Doses Administered To 12-14 Age Group: Centre
Over three crore children in the age group of 12-14 years have been administered the first dose of the COVID-19 vaccine, said Union Health Minister Mansukh Mandaviya said on Tuesday.
-
US Limits Johnson & Johnson Covid Vaccine Use Over Rare Blood Clot Risk
The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition.
-
Moderna Seeks US Approval For Covid Vaccine For Children Under 6
US biotech firm Moderna said Thursday it had submitted a request for an emergency use authorization in the United States for its Covid vaccine for children aged six months to under six years.
-
Over 18.03 Crore Covid Vaccine Doses Available With States, UTs: Centre
More than 18.03 crore balanced and unutilized COVID vaccine doses are still available with states and Union Territories (UTs), informed the Ministry of Health and Family Welfare in its official statement on Monday.
